RSV risk rises for elderly in multi‑generational Taiwanese households

Respiratory syncytial virus (RSV) is increasingly recognised as a serious threat to adults over 60 and people with chronic conditions, with severe‑illness risk estimated at twice that of influenza. The virus presents early symptoms similar to a common cold—runny nose, mild fever, sore throat—making early detection difficult. Clinicians stress that persistent coughing, worsening breathlessness, nighttime coughing, and wheezing warrant prompt medical evaluation rather than continued self‑medication.

In southern Taiwan, where three‑ and four‑generation families are common, caregivers of infants can inadvertently transmit RSV to older relatives. The virus spreads via droplets and respiratory secretions, with a typical patient infecting about three others. High‑risk groups—including seniors, adults with diabetes, chronic lung, heart, kidney disease, or weakened immunity—should watch for worsening symptoms and seek care. Although no specific antiviral treatment exists, newly developed mRNA‑based RSV vaccines are now available for adults over 60 and high‑risk younger adults, offering an additional preventive option alongside annual flu shots.